Axillary dissection can be avoided in selected breast cancer patients: Analysis of 401 cases

Anticancer Research

Volumn 16, Issue 6 C, 1996, Pages 3913-3918

  Greco, Marco ^a   Agresti, Roberto ^a   Raselli, Roberta ^a   Giovanazzi, Riccardo ^a   Veronesi, Umberto ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Axillary dissection; Breast cancer; Surgical therapy

Indexed keywords

HORMONE RECEPTOR;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES;

EID: 0030513616     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Halverson KJ, Taylor ME, Ferez CA, Garcia DM, Myerson R, Philpott G, Levy J, Simpson JR, Tucker G and Rush C: Management of the axilla in patients with breast cancers one centimeter or smaller. Am J Clin Oncol 17: 461-466, 1994.
2. Chanda M, Chabon AB, Friedmann P: Predictors of axillary lymp node metastases in patients with T1 breast cancer. A multivaried analysis. Cancer 73: 350-353, 1994.
3. Veroncsi U, Ballfi A, Salvadori B et al: Breast conservation is the treatment of choice breast cancer: long term results of randomized trial. Eur J Cancer 26:668-670, 1990.
4. Reger V, Beito G, Jolly PC: Factors affecting the incidence of lymphnode metastases in small cancers of the breast. Am J Surg 157; 501-502. 1989.
5. Silverstein MJ, Gierson ED, Waisman JR: Axillary lymph node dissection for 11 a breast carcinoma. Is it indicated? Cancer 73: 664-667, 1994.